MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


Emis rise in revenue overshadowed by mounting costs as profit slips

ALN

Emis Group PLC on Thursday reported increased revenue in 2021, due to a recovery in its Health segment and growth in its Enterprise arm, but profit fell on increased expenses.

The Leeds-based company, which makes software used by healthcare providers, posted a pretax profit of £36.1 million in 2021. This reflects a 2.2% decrease from £36.9 million posted in 2020.

Profit was hurt by operating expenses that increased 18% to £26.7 million from £22.6 million and staff costs that rose 14% to £72.3 million from £63.4 million. Further, Emis received a payment of £782,000 in 2020 in relation to the disposal of its Specialist & Care business in 2019.

Full-year revenue increased by 5.5% to £168.2 million from £159.5 million the year before.

The company credited the growth in revenue to a ‘more normal’ trading pattern in its Emis Health segment following a hit by the pandemic in 2020. Double-digit revenue growth in its Emis Enterprise also contributed to the growth.

Emis proposed a final dividend of 17.6 pence, up 10% compared to the final of 16.0p in 2020. Its total dividend amounted to 35.2p, reflecting 10% growth from 32.0p the year before.

Looking ahead, Emis believes that its strong balance sheet will provide the platform to deliver organic and inorganic growth ambitions.

Emis said it will remain focused on delivering consistent revenue growth, as well as expanding margins over time.

In 2021, its operating margin fell to 21.3% from 22.4% in 2020.

‘It has been a positive year of good growth and margin performance driving strong results, with the group delivering the eleventh consecutive year of dividend growth,’ Chief Executive Andy Thorburn said.

‘Emis Group is well placed with products directly aligned to market need, including integrated care software to the NHS, and data and analytics technology to the research and life sciences industry. This will be critical as the sector looks to provide the best healthcare possible to the UK population.’

Shares were up 0.3% at 1,254.00 pence each on Thursday morning in London.

Copyright 2022 Alliance News Limited. All Rights Reserved.